Ketamine Troches vs. IV Infusions: A Complete Comparison

Overview

Ketamine troches and IV infusions represent two fundamentally different approaches to ketamine therapy. IV infusions are administered in a clinical setting with direct medical supervision, delivering ketamine directly into the bloodstream. Troches are compounded lozenges that dissolve under the tongue at home, absorbed through the oral mucosa.

Both routes deliver the same active medication — racemic ketamine — but differ substantially in bioavailability, onset, cost, and practical considerations. For outcome data, see our remission rates comparison.

Bioavailability and Onset

The most significant pharmacological difference between the two routes is bioavailability:

IV infusions deliver the full dose directly to the bloodstream, while troches lose a significant portion through incomplete absorption and some first-pass metabolism from swallowed saliva. However, the gradual absorption of troches creates a smoother onset that many patients find more comfortable.

Cost Comparison

Cost is where troches have a decisive advantage:

• Troches: $1-15 per dose, self-administered at home. Monthly cost typically $100-400 including provider consultations
• IV Infusions: $400-800 per session. Initial series of 6 infusions may cost $2,400-4,800. Maintenance infusions every 3-6 weeks add ongoing expense

Neither troches nor standard IV ketamine infusions are typically covered by insurance. Over a 12-month period, troche therapy may cost $1,200-4,800 compared to $4,800-12,000+ for IV infusions.

Convenience and Accessibility

Troches allow patients to administer ketamine in the comfort of their home on their own schedule. IV infusions require:

• Traveling to a specialized clinic
• Scheduling appointments during business hours
• Spending 2-3 hours per session (including monitoring)
• Arranging transportation (you cannot drive after either treatment)

For patients in rural areas or those with mobility limitations, troches dramatically improve access to ketamine therapy.

Clinical Supervision

IV infusions provide direct medical monitoring throughout the session, including vital sign tracking and immediate access to medical intervention if needed. This is particularly valuable for:

• Patients new to ketamine therapy
• Those with cardiovascular risk factors
• Higher-dose protocols
• Patients who have had adverse reactions previously

Troche therapy typically involves periodic telehealth check-ins with a prescribing provider, with patients monitoring their own experience at home.

Effectiveness

Research comparing sublingual/oral ketamine to IV ketamine for depression is still evolving. Key findings include:

• IV ketamine has the most robust evidence base, particularly for rapid response in treatment-resistant depression
• Sublingual ketamine has shown promising results in several studies, though with somewhat less rapid onset of antidepressant effects
• For maintenance therapy after initial response, troches may be equally effective and more sustainable long-term
• Both routes show efficacy for chronic pain conditions

The choice between routes often depends on whether rapid acute response or sustainable long-term maintenance is the primary goal.

References

• Comparison of Ketamine Administration Routes — Systematic review of ketamine bioavailability by route
• IV Ketamine for Treatment-Resistant Depression — Meta-analysis of IV ketamine efficacy
• At-Home Oral Ketamine for Depression — Real-world outcomes with at-home ketamine therapy
• NIMH: Ketamine Research Updates — Latest research from the National Institute of Mental Health